These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27802280)

  • 1. Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame.
    Lau CL; Won KY; Lammie PJ; Graves PM
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005108. PubMed ID: 27802280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
    Lau CL; Sheridan S; Ryan S; Roineau M; Andreosso A; Fuimaono S; Tufa J; Graves PM
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005914. PubMed ID: 28922418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration.
    Lau CL; Won KY; Becker L; Soares Magalhaes RJ; Fuimaono S; Melrose W; Lammie PJ; Graves PM
    PLoS Negl Trop Dis; 2014; 8(11):e3297. PubMed ID: 25393716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American Samoa.
    Schmaedick MA; Koppel AL; Pilotte N; Torres M; Williams SA; Dobson SL; Lammie PJ; Won KY
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3087. PubMed ID: 25122037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing 'number needed to test' by targeting older age groups, hotspots, and household members of infected persons.
    Lau CL; Sheel M; Gass K; Fuimaono S; David MC; Won KY; Sheridan S; Graves PM
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008916. PubMed ID: 33370264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular xenomonitoring as an indicator of microfilaraemia prevalence for lymphatic filariasis in Samoa in 2019.
    Howlett M; Mayfield HJ; McPherson B; Rigby L; Thomsen R; Williams SA; Pilotte N; Hedtke SM; Graves PM; Kearns T; Naseri T; Sheridan S; McLure A; Lau CL
    Parasit Vectors; 2024 Sep; 17(1):382. PubMed ID: 39252131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug ad ministration surveillance in American Samoa.
    Cadavid Restrepo AM; Gass K; Won KY; Sheel M; Robinson K; Graves PM; Fuimaono S; Lau CL
    Int J Infect Dis; 2022 Apr; 117():378-386. PubMed ID: 35150913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of traps and lures for mosquito vectors and xenomonitoring of Wuchereria bancrofti infection in a high prevalence Samoan Village.
    Hapairai LK; Plichart C; Naseri T; Silva U; Tesimale L; Pemita P; Bossin HC; Burkot TR; Ritchie SA; Graves PM; Melrose W; Joseph H
    Parasit Vectors; 2015 May; 8():287. PubMed ID: 26016830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa.
    Won KY; Robinson K; Hamlin KL; Tufa J; Seespesara M; Wiegand RE; Gass K; Kubofcik J; Nutman TB; Lammie PJ; Fuimaono S
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006347. PubMed ID: 29522520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects, drawbacks and future needs of xenomonitoring for the endpoint evaluation of lymphatic filariasis elimination programs in Africa.
    Okorie PN; de Souza DK
    Trans R Soc Trop Med Hyg; 2016 Feb; 110(2):90-7. PubMed ID: 26822601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014.
    Graves PM; Sheridan S; Fuimaono S; Lau CL
    Parasit Vectors; 2020 Mar; 13(1):125. PubMed ID: 32164780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial predictive risk mapping of lymphatic filariasis residual hotspots in American Samoa using demographic and environmental factors.
    Cadavid Restrepo AM; Martin BM; Fuimaono S; Clements ACA; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0010840. PubMed ID: 37486947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis endgame strategies: Using GEOFIL to model mass drug administration and targeted surveillance and treatment strategies in American Samoa.
    Shaw C; McLure A; Graves PM; Lau CL; Glass K
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011347. PubMed ID: 37200375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian Network Analysis of Lymphatic Filariasis Serology from Myanmar Shows Benefit of Adding Antibody Testing to Post-MDA Surveillance.
    Dickson BFR; Masson JJR; Mayfield HJ; Aye KS; Htwe KM; Roineau M; Andreosso A; Ryan S; Becker L; Douglass J; Graves PM
    Trop Med Infect Dis; 2022 Jun; 7(7):. PubMed ID: 35878125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission.
    Dorkenoo MA; de Souza DK; Apetogbo Y; Oboussoumi K; Yehadji D; Tchalim M; Etassoli S; Koudou B; Ketoh GK; Sodahlon Y; Bockarie MJ; Boakye DA
    Parasit Vectors; 2018 Jan; 11(1):52. PubMed ID: 29361964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an urban molecular xenomonitoring system for lymphatic filariasis in the Recife Metropolitan Region, Brazil.
    Ramesh A; Cameron M; Spence K; Hoek Spaans R; Melo-Santos MAV; Paiva MHS; Guedes DRD; Barbosa RMR; Oliveira CMF; Sá A; Jeffries CL; Castanha PMS; Oliveira PAS; Walker T; Alexander N; Braga C
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006816. PubMed ID: 30325933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration.
    McLure A; Graves PM; Lau C; Shaw C; Glass K
    Epidemics; 2022 Sep; 40():100591. PubMed ID: 35816826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.